+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Xerostomia (Dry Mouth) Therapeutics - Global Strategic Business Report

  • PDF Icon

    Report

  • 92 Pages
  • December 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5303834

Quick Summary:

As the healthcare industry continues to evolve, the Global Xerostomia (Dry Mouth) Therapeutics Market presents far-reaching opportunities for key players and strategists. Currently estimated at a considerable US$704.1 Million, projections indicate promising growth, with a revised target of US$1 Billion by 2030. Comprising over-the-counter and prescription segments, the market promises significant gains in both areas, each exhibiting steady predicted growth over the next 8-year period.

Furthering its global scope, this report provides an insightful coverage of geographical markets beyond the US. China's market, driven by the world's second largest economy, is forecast to grow impressively at a CAGR of 7.4% in the period 2022 to 2030. There are also notable predictions for Japan, Canada, and Germany, each showing promising trajectories. Equip yourself with this crucial knowledge from competitors' market shares, to geographical presence, and more, crucial for informed strategic decision-making in this thriving market.

Global Xerostomia (Dry Mouth) Therapeutics Market to Reach $1 Billion by 2030

The global market for Xerostomia (Dry Mouth) Therapeutics estimated at US$704.1 Million in the year 2022, is projected to reach a revised size of US$1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Over-the-Counter, one of the segments analyzed in the report, is projected to record 4.7% CAGR and reach US$603.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prescription segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $191.8 Million, While China is Forecast to Grow at 7.4% CAGR

The Xerostomia (Dry Mouth) Therapeutics market in the U.S. is estimated at US$191.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$209.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Select Competitors (Total 36 Featured) -

  • 3M company
  • Advanz Pharma Corp. Limited
  • Bausch Health Companies Inc.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Parnell Pharmaceuticals Inc.
  • Pharmascience Inc (Pendopharm)
  • Quest Products Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Xerostomia (Dry Mouth) Therapeutics

What is the estimated value of the Global Market for Xerostomia (Dry Mouth) Therapeutics?

The Global Market for Xerostomia (Dry Mouth) Therapeutics was estimated to be valued at $704.1 Million in 2022.

What is the growth rate of the Global Market for Xerostomia (Dry Mouth) Therapeutics?

The growth rate of the Global Market for Xerostomia (Dry Mouth) Therapeutics is 4.5%, with an estimated value of $1000 Million by 2030.

What is the forecasted size of the Global Market for Xerostomia (Dry Mouth) Therapeutics?

The Global Market for Xerostomia (Dry Mouth) Therapeutics is estimated to be worth $1000 Million by 2030.

Who are the key companies in the Global Market for Xerostomia (Dry Mouth) Therapeutics?

Key companies in the Global Market for Xerostomia (Dry Mouth) Therapeutics include 3M company, Advanz Pharma Corp. Limited, Bausch Health Companies Inc., Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Lupin Limited, Parnell Pharmaceuticals Inc., Pharmascience Inc (Pendopharm) and Quest Products Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Xerostomia (Dry Mouth) Therapeutics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Over-the-Counter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Over-the-Counter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Over-the-Counter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Prescription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Prescription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Prescription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Dentifrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Dentifrices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Dentifrices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Salivary Stimulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Salivary Stimulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Salivary Stimulants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Salivary Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Salivary Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Salivary Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Xerostomia (Dry Mouth) Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: USA Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: USA 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: USA 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Canada 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Canada 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
JAPAN
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Japan 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Japan 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
CHINA
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: China Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: China 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: China 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
EUROPE
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Europe 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
FRANCE
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 53: France Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: France Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: France 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: France 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
GERMANY
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 59: Germany Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: Germany 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: Germany 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: Italy 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Italy 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 71: UK Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: UK Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: UK 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: UK 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
SPAIN
  • Table 77: Spain Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: Spain Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: Spain 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 80: Spain Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: Spain 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
RUSSIA
  • Table 83: Russia Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Russia Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: Russia 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 86: Russia Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Russia 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Xerostomia (Dry Mouth) Therapeutics by Type - Over-the-Counter and Prescription Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Type - Percentage Breakdown of Value Sales for Over-the-Counter and Prescription for the Years 2014, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Dentifrices, Salivary Stimulants and Salivary Substitutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Xerostomia (Dry Mouth) Therapeutics by Product Segment - Percentage Breakdown of Value Sales for Dentifrices, Salivary Stimulants and Salivary Substitutes for the Years 2014, 2023 & 2030
AUSTRALIA
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Xerostomia (Dry Mouth) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M company
  • Advanz Pharma Corp. Limited
  • Bausch Health Companies Inc.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Parnell Pharmaceuticals Inc.
  • Pharmascience Inc (Pendopharm)
  • Quest Products Inc.